Phospholipid formulations
CA 2181390 C · Owner: Modi, Pankaj · Inventors: Modi, Pankaj
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A medicinally active formulation contains i) at least three compounds selected from the group consisting of egg phosphatidylcholine, dilauryl phosphatidylcholine dimyristoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine, dioleoyl phosphatidylcholine dimyristoyl phosphatidylglycerol, dipalmitoyl phosphatidylglycerol, dimyristoyl phosphatidic acid dipalmitoyl phosphatidic acid, dipalmitoyl phosphatidylethanolamine, distearoyl, phosphatidylcholine brain phosphatidylserine, brain, sphingomyelin cholesterol, cardiolipin, trioctanoin, triolein soy phosphatidylcholine, poly(adenylic acid) phosphatidylethanolamine, phosphatidyl glycerol phosphatidyl inositol, sphingosine, cerebroside …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 17, 1996 and granted April 24, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 17, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 17, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.